ArticleJournal of robotic surgery2026
Robot-assisted kidney transplantation in living and deceased donors: a six-year experience.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robot-assisted kidney transplantation (RAKT) is increasingly adopted, but reports describing large-volume programs with predominantly deceased-donor transplantation, increasing procedural complexity, and experience across both single-port (SP) and multiport (MP) robotic platforms remain limited. In this retrospective, single-center study, we reviewed a prospectively maintained registry of patients who underwent RAKT between October 2019 and December 2025 and evaluated perioperative, postoperative, and allograft outcomes. A total of 228 patients underwent RAKT, including 125 (54.8%) deceased-donor kidney transplants (DDKT) and 103 (45.2%) living-donor kidney transplants (LDKT). SP and MP platforms were utilized in 30.7% and 69.3% of cases, respectively. Six patients received dual-kidney transplants and four underwent simultaneous kidney-pancreas transplantation. Annual case volume increased from one procedure in 2019 to 115 procedures in 2025. Median operative times were 3 h 38 min for DDKT and 4 h 6 min for LDKT, with median vascular anastomosis times of 44 and 40 min, respectively. Conversion to open surgery occurred in one patient (0.4%). Median length of stay was four days for DDKT and two days for LDKT. Delayed graft function occurred in 30.4% of DDKT recipients and 4.8% of LDKT recipients; among the 121 recipients with available one-year serum creatinine, median one-year serum creatinine was 1.49 mg/dL and 1.37 mg/dL, respectively. Graft-loss occurred in two DDKT recipients (1.6%) and one LDKT recipient (0.9%), while three deaths (2.4%) occurred after DDKT and one death (0.9%) after LDKT. In this large single-center experience, RAKT was associated with low conversion rates, favorable perioperative outcomes, and good one-year graft function despite increasing procedural complexity, supporting its continued expansion in appropriately selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.